Eliem Therapeutics’ $60-Million Series B Financing

Brown Rudnick LLP advised Eliem Therapeutics on the deal.Eliem Therapeutics Inc. recently closed on a $60-million Series B financing.  Eliem is a clinical-stage biotechnology company focused…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here